Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2005-03-15
2005-03-15
Nolan, Patrick J. (Department: 1644)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S195110, C514S012200, C514S016700, C530S324000, C530S329000
Reexamination Certificate
active
06866848
ABSTRACT:
An antigenic polypeptide of factor VIII comprises a polypeptide included between the Glutamic Acid 1649 and Asparagine 2019, preferably between Arginine 1652 and Arginine 1917 of the polypeptide of factor VIII, or a polypeptide included between Alanine 108 and Methionine 355, or a polypeptide included between Aspartic Acid 403 and Aspartic Acid 725, or a polypeptide included between Lysine 2085 and Lysine 2249.
REFERENCES:
patent: 4965199 (1990-10-01), Capon et al.
Vehar et al., Nature 312:337-342, 1984.*
Van Regenmortel. Methods: A Companion to Method of Enzymology, 9:465-472, 1996.*
Palmer et al., Vox Sang. 72:148-161, 1996.
Di Giambattista Mario
Laub Ruth
Croix-Rouge de Belgique
Knobbe Martens Olson & Bear, L.L.P.
Nolan Patrick J.
LandOfFree
Antigenic polypetide sequence of factor VIII, fragments... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antigenic polypetide sequence of factor VIII, fragments..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigenic polypetide sequence of factor VIII, fragments... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3431991